@DougT comparables include ADO @ approx $589M market cap BD1 would be approx $7.40, and i think investors will take it here
in terms of value look at similar pathology co’s that our CEO here was an executive in - looking @ circa $15billion USD market cap as commercialisation occurs
The evidence from the Covid pathology testing pathways indicates that pathology that has breakthrough designation / life saving potential can be quick to market
100%/100% is out of this world
I may share some shares with other investors to down risk but will hold majority of portfolio for this story
@DougT comparables include ADO @ approx $589M market cap BD1...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
-0.025(4.50%) |
Mkt cap ! $60.22M | |||
| Open | High | Low | Value | Volume |
| 55.5¢ | 55.5¢ | 53.0¢ | $38.59K | 70.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7170 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 3198 | 2 |
View Market Depth
| Last trade - 12.29pm 10/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |